CLL: Transformation in Treatment

Ellin Berman, MD Join us as Ellin Berman, MD a leukemia expert from Memorial Sloan Kettering Cancer Center discusses the advancements in treatment for Chronic Lymphocytic Leukemia (CLL). Dr. Berman explains how not all CLL is the same, as it is a heterogeneous disease which explains why one person’s CLL can act differently from another person’s CLL.  Dr. Berman speaks about how some patients do not start treatment right away and why some patients may be good candidates for clinical trials.  Every patient is different, and since there are newer treatments now available for CLL, Dr. Berman provides patients with different treatment options, and encourages patients to ask questions and to be a partner with their treatment team when making treatment decisions. Download Transcript CLICK HERE to participate in our episode survey. Mentioned on this episode: Chronic Lymphocytic Leukemia (CLL)Printable Question to ask your DoctorMemorial Sloan KetteringClinical Trial Support Center (CTSC)Ibrutinib Additional LLS Support Resources: Information SpecialistsFree telephone/web patient programsFree bookletsFinancial supportOnline chatsCaregiver supportLLS CommunitySupport groupsPatti Robinson Kaufmann First Connection ProgramFree Nutrition Consultations Support for this episode provided by Pharmacyclics/Janssen. The post CLL: Transformation in Treatment first appeared on The Bloodline with Blood Cancer United Podcast.